Novo Nordisk
Jul 11, 2026, 21:43
Sharing New Research in Hemophilia at ISTH 2026 – Novo Nordisk Medical US
Novo Nordisk Medical US shared a post on X:
“Heading to ISTH 2026 in Paris?
We look forward to sharing new research in hemophilia at the congress.
Here is a snapshot of our oral presentations. Feel free to stop by booth 907 to engage with the Novo Nordisk medical team.
Visit the ISTH congress program for more details.”
Proceed to the video attached to the post.
Stay Updated with ISTH 2026 on Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention